Drug targets discovery based on dynamic signal transduction networks

Yaoxue Xuebao

Volumn 45, Issue 1, 2010, Pages 1-8

  Wang, Juan ^a   Li, Xue Jun ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cellular signal transduction network; Drug target; System modeling; Systems biology

Indexed keywords

4 [N [1 (2 CYANO 1 OXOETHYL) 4 METHYL 3 PIPERIDINYL] N METHYLAMINO]PYRROLO[2,3 D]PYRIMIDINE; BCR ABL PROTEIN; DASATINIB; ERLOTINIB; G PROTEIN COUPLED RECEPTOR; IMATINIB; JANUS KINASE; LAPATINIB; MIDOSTAURIN; NILOTINIB; PAZOPANIB; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RAF PROTEIN; SORAFENIB; SUNITINIB; VANDETANIB;

COMPUTER PROGRAM; DRUG RESEARCH; DRUG TARGETING; ENZYME INHIBITION; HUMAN; INTERNET; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

CELL MOVEMENT; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; HUMANS; INTERNET; PEPTIDE HYDROLASES; PHOSPHORYLATION; PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 77950602744     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Keyhani S, Diener-West M, Powe N. Are development times for pharmaceuticals increasing or decreasing? [J]. Health Aff (Millwood), 2006, 25, 461-468.
2. Hopkins AL. Network pharmacology: the next paradigm in drug discovery [J]. Nat Chem Biol, 2008, 11: 682-690.
3. Frantz S. Drug discovery: playing dirty [J]. Nature, 2005, 437: 942-943.
4. Kitano H. A robustness-based approach to systems-oriented drug design [J]. Nat Rev Drug Discov, 2007: 202-210. (Pubitemid 46344624)
5. Goh KI, Cusick ME, Valle D, et al. The human disease network [J]. Proc Natl Acad Sci USA, 2007, 104: 8685-8690.
6. Daniel MR, Søren GFR, Brian KK. The structure and function of G-protein-coupled receptors [J]. Nature, 2009, 459: 356-363.
7. Linding R, Jensen LJ, Ostheimer GT, et al. Systematic discovery of in vivo phosphorylation networks [J]. Cell, 2007, 129: 1415-1426. (Pubitemid 46962092)
8. Kumar N, Wolf-Yadlin A, White FM, et al. Modeling HER2 effects on cell behavior from mass-spectrometry phosphotyrosine data [J]. PLoS Comput Biol, 2007, 3: e4.
9. Hansen KK, Oikonomopoulou K, Baruch A, et al. Proteinases as hormones: targets and mechanisms for proteolytic signaling [J]. Biol Chem, 2008, 389: 971-982.
10. Olsen JV, Blagoev B, Gnad F, et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks [J]. Cell, 2006, 127: 635-648. (Pubitemid 44647421)
11. Pawsona T, Linding R. Network medicine [J]. FEBS Lett, 2008, 582: 1266-1270.
12. Miller ML, Jensen LJ, Diella F, et al. Linear motif atlas for phosphorylation-dependent signaling [J]. Sci Signal, 2008, 1: 2.
13. Kestler HA, Wawra C, Kracher B, et al. Network modeling of signal transduction: establishing the global view [J]. Bioessays, 2008, 30: 1110-1125.
14. Liu Y, Chen Z, Shang EC, et al. Controlling aracbidonic acid metabolic network: from single- to multi-target inhibitors of key enzymes [J]. Acta Pharm Sin, 2009, 44: 231-241.
15. Wu W, Lu C, Chen SY, et al. The signal transduction pathway of multi-target kinase inhibitors as anticancer agents in clinical use or in phase III [J]. Acta Pharm Sin, 2009, 44: 242-257.
16. Wolf-Yadlin A, Hautaniemi S, Lauffenburger DA, et al. Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks [J]. Proc Natl Acad Sci USA, 2007, 104: 5860-5865. (Pubitemid 47175624)
17. Chittenden TW, Howe EA, Culhane AC, et al. Functional classification analysis of somatically mutated genes in human breast and colorectal cancers [J]. Genomics, 2008, 91: 508-511.
18. Chuang HY, Lee E, Liu YT, et al. Network-based classification of breast cancer metastasis [J]. Mol Syst Biol, 2007, 140. (Pubitemid 47587026)
19. Miller-Jensen K, Janes KA, Brugge JS, et al. Common effector processing mediates cell-specific responses to stimuli [J]. Nature, 2007, 448: 604-608. (Pubitemid 47206933)
20. Schrattenholz A, Soskić V. What does systems biology mean for drug development? [J]. Curr Med Chem, 2008, 15: 1520-1528.
21. Pujana MA, Han JD, Starita LM, et al. Network modeling links breast cancer susceptibility and centrosome dysfunction [J]. Nat Genet, 2007, 39: 1338-1349. (Pubitemid 350035000)
22. Schadt EE, Friend SH, Shaywitz DA. A network view of disease and compound screening [J]. Nat Rev Drug Discov, 2009, 8: 286-295.